Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) CEO Bradford C. Connett sold 4,036 shares of the firm’s stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares in the company, valued at $4,460,251.20. This represents a 6.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.
Henry Schein Stock Performance
NASDAQ:HSIC traded down $0.39 during trading hours on Thursday, reaching $70.45. The company had a trading volume of 1,151,604 shares, compared to its average volume of 1,506,691. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.49. The business’s 50 day moving average price is $74.84 and its 200-day moving average price is $72.62. The firm has a market cap of $8.75 billion, a PE ratio of 28.99, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90.
Henry Schein (NASDAQ:HSIC – Get Free Report) last posted its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.66 earnings per share. Research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.
Wall Street Analyst Weigh In
Get Our Latest Analysis on Henry Schein
Institutional Investors Weigh In On Henry Schein
A number of institutional investors have recently modified their holdings of HSIC. Wealth Enhancement Advisory Services LLC grew its holdings in Henry Schein by 34.0% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 52,891 shares of the company’s stock valued at $3,660,000 after purchasing an additional 13,431 shares during the period. Siemens Fonds Invest GmbH raised its stake in shares of Henry Schein by 282.3% during the 4th quarter. Siemens Fonds Invest GmbH now owns 13,366 shares of the company’s stock worth $925,000 after buying an additional 9,870 shares during the period. Menard Financial Group LLC purchased a new position in shares of Henry Schein during the 4th quarter valued at approximately $92,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Henry Schein in the 4th quarter valued at $5,743,000. Finally, Jefferies Financial Group Inc. increased its holdings in Henry Schein by 98.8% in the 4th quarter. Jefferies Financial Group Inc. now owns 83,100 shares of the company’s stock worth $5,751,000 after acquiring an additional 41,300 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading
- Five stocks we like better than Henry Schein
- How to Find Undervalued Stocks
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.